Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer. Its lead immuno-oncology drug candidate, sotigalimab, is a potent immune-activating antibody against CD40 currently in Phase 2 clinical development.
Company Details
- Employees
- 10
- Address
- 75 Shoreway Road Suite C, San Carlos,california 94070,united States
- Phone
- 6509316236
- in****@****gen.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- apexigen.com
- HQ
- San Carlos, California
Apexigen Questions
Apexigen's helpline number is 6509316236
Apexigen's website is apexigen.com
Apexigen's LinkedIn profile is https://www.linkedin.com/company/apexigen
Apexigen has
10 employees.
View email and phone details for 10
employees at Apexigen.
Apexigen's industry is
Biotechnology Research
Apexigen's top competitors are
Jade Biosciences,
Tessera Therapeutics,
Allogene Therapeutics,
Olema Oncology,
Himalaya Therapeutics,
Pyxis Oncology,
Vertex Pharmaceuticals,
Immunitas Therapeutics,
Kura Oncology, Inc.,
Pliant Therapeutics.
Apexigen's support email address is info@apexigen.com
Apexigen's categories are Biotechnology Research
